As the year draws to a close it is time to reflect on 2020. Despite it being a very strange year, and having to down tools to help with inpatient COVID-19 cover in @LeedsHospitals, our research group has enjoyed considerable academic success. Here are 10 personal highlights:
In March, as I recovered from COVID-19 myself, I was awarded the @RomeFoundation Aldo Torsoli award for research into disorders of gut-brain interaction. https://theromefoundation.org/programs-projects/research-program/rome-foundation-aldo-torsoli-foundation-research-award/2020-aldo-torsoli-award-winner/
My research fellow @DrCJBlack completed a series of network meta-analyses examining the efficacy of various pharmacological therapies for #IBS, published in @GutBMJ and @LancetGastroHep: https://gut.bmj.com/content/69/1/74.long
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(19)30324-3/fulltext
@DrCJBlack also published a network meta-analysis of psychological therapies in #IBS, which was published in @Gut_BMJ: https://gut.bmj.com/content/69/8/1441.long
With our visiting Italian fellow, @bribarberio, we updated our meta-analyses on epidemiology of both irritable bowel syndrome and functional dyspepsia, publishing them in @APT and @LancetGastroHep: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(20)30217-X/fulltext
https://onlinelibrary.wiley.com/doi/abs/10.1111/apt.16006
With the help of patients attending our specialist #IBS clinic in Leeds we performed the first independent validation study of the Rome IV criteria for #IBS, comparing them with their predecessor, the Rome III criteria. Again, published in @GutBMJ: https://gut.bmj.com/content/early/2020/09/23/gutjnl-2020-322519.long
I was invited by @TheLancet to assemble a team of experts to provide a series of 3 articles dealing with functional gastrointestinal disorders. These articles are now in print and are accompanied by amazing infographics designed by the journal:https://www.thelancet.com/series/functional-gastrointestinal-disorders
@DrCJBlack used a complex statistical technique, called latent class analysis, to identify a potentially novel subgrouping system for patient with #IBS based on factors other than stool form alone, which was published in @AmJGastro: https://journals.lww.com/ajg/Abstract/9000/A_Novel_Method_to_Classify_and_Subgroup_Patients.99045.aspx
With @PaulMoayyedi and @justntweet we performed the first network meta-analysis of pharmacological therapies for functional dyspepsia, demonstrating efficacy of tricyclic antidepressants for the condition, and published in @APT:https://onlinelibrary.wiley.com/doi/abs/10.1111/apt.16072
And on a related note, despite the pandemic, and thanks to our dedicated research nurses and @LeedsCTRU staff, @HazelEveritt, @amanda_horler and I are pleased to report the @NIHRResearch-funded @ATLANTISTrial of amitriptyline is still recruiting, with 110 patients randomised.
Finally, in November, based on the number of highly cited papers our research group had produced between 2009 and 2019, I was listed as a @clarivate highly cited researcher for 2020. #HighlyCited 2020. @MedicineDean
A notable year for a multitude of reasons! Here's wishing everyone a merry Christmas, a happy New Year, and an altogether better 2021.
Read on Twitter